Keratoconjunctival effects of diabetes mellitus in dogs

Veterinary Ophthalmology

Volumn 8, Issue 4, 2005, Pages 215-224

  Cullen, Cheryl L ^a   Ihle, Sherri L ^a   Webb, Aubrey A ^a   McCarville, Carole ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Conjunctival microflora; Corneal sensitivity; Glycemic control; Goblet cells; Tear film break up time; Tear glucose

Indexed keywords

GLUCOSE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONJUNCTIVA; CORNEA DISEASE; CYTOLOGY; DIABETES MELLITUS; DOG; DOG DISEASE; FEMALE; GOBLET CELL; LACRIMAL FLUID; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION; VISUAL SYSTEM EXAMINATION;

ANIMALS; CASE-CONTROL STUDIES; CONJUNCTIVA; CORNEAL DISEASES; DIABETES MELLITUS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DOG DISEASES; DOGS; FEMALE; GLUCOSE; GOBLET CELLS; MALE; TEARS;

CANIS FAMILIARIS;

EID: 22244464843     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2005.00389.x     Document Type: Article

References (47)

1. Marmor M, Willeberg P, Glickman LT et al. Epizootiologic patterns of diabetes mellitus in dogs. American Journal of Veterinary Research 1982; 43: 465-470.
2. Sato S, Takahashi Y, Wyman M et al. Progression of sugar cataract in the dog. Investigative Ophthalmology and Visual Science 1991; 32: 1925-1931.
3. Yee RW, Matsuda M, Kern TS et al. Corneal endothelial changes in diabetic dogs. Current Eye Research 1985; 4: 759-766.
4. Datiles MB, Kador PF, Kashima K et al. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs. Investigative Ophthalmology and Visual Science 1990; 31: 2201-2204.
5. Good KL, Maggs DJ, Hollingsworth SR et al. Corneal sensitivity in dogs with diabetes mellitus. American Journal of Veterinary Research 2003; 64: 7-11.
6. Kador PF, Akagi Y, Takahashi Y et al. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Archives of Ophthalmology 1990; 108: 1301-1309.
7. Basher AW, Roberts SM. Ocular manifestations of diabetes mellitus: diabetic cataracts in dogs. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 661-676.
8. Beam S, Correa MT, Davidson MG. A retrospective-cohort study on the development of cataracts in dogs with diabetes mellitus: 200 cases. Veterinary Ophthalmology 1999; 2: 169-172.
9. Schultz RO, Van Horn DL, Peters MA et al. Diabetic keratopathy. Transactions of the American Ophthalmological Society 1981; 79: 180-199.
10. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001; 108: 586-592.
11. Desai BM, Lavingia BC. Cornea thickness and tear glucose levels in diabetes mellitus and normal persons. Indian Journal of Ophthalmology 1987; 35: 130-132.
12. Burgard AP, Vaidyaraman S, Maranas CD. Minimal reaction sets for Escherichia coli metabolism under different growth requirements and uptake environments. Biotechnology Progress 2001; 17: 791-797.
13. McDonald PJ, Watson DJ. Microbial flora of normal canine conjunctivae. Journal of Small Animal Practice 1976; 17: 809-812.
14. Samuelson DA, Andresen TL, Gwin RM. Conjunctival fungal flora in horses, cattle, dogs, and cats. Journal of the American Veterinary Medical Association 1984; 184: 1240-1242.
15. Urban M, Wyman M, Rheins M et al. Conjunctival flora of clinically normal dogs. Journal of the American Veterinary Medical Association 1972; 161: 201-206.
16. Murphy JM, Lavach JD, Severin GA. Survey of conjunctival flora in dogs with clinical signs of external eye disease. Journal of the American Veterinary Medical Association 1978; 172: 66-68.
17. Mino D K, Shriver EM, Nguyen EV et al. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefe's Archive for Clinical and Experimental Ophthalmology 2003; 241: 730-733.
18. Cullen CL, Njaa BL, Grahn BH. Ulcerative keratitis associated with qualitative tear film abnormalities in cats. Veterinary Ophthalmology 1999; 2: 197-204.
19. Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. British Journal of Ophthalmology 2000; 84: 19-21.
20. Barrera R, Cinta MM, Rodriguez JF et al. Keratoconjunctivitis sicca and diabetes mellitus in a dog. Journal of the American Veterinary Medical Association 1992; 200: 1967-1968.
21. Briggs CE, Nelson RW, Feldman EC et al. Reliability of history and physical examination findings for assessing control of glycemia in dogs with diabetes mellitus: 53 cases (1995-1998). Journal of the American Veterinary Medical Association 2000; 217: 48-53.
22. Herring IP, Pickett JP, Champagne ES et al. Evaluation of aqueous tear production in dogs following general anesthesia. Journal of the American Animal Hospital Association 2000; 36: 427-430.
23. Hollingsworth SR, Canton DD, Buyukmihci NC et al. Effect of topically administered atropine on tear production in dogs. Journal of the American Veterinary Medical Association 1992; 200: 1481-1484.
24. Ludders JW, Heavner JE. Effect of atropine on tear formation in anesthetized dogs. Journal of the American Veterinary Medical Association 1979; 175: 585-586.
25. Moore CP, Collier LL. Ocular surface disease associated with loss of conjunctival goblet cells in dogs. Journal of the American Animal Hospital Association 1990; 26: 458-466.
26. Moore CP. Qualitative tear film disease. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 565-581.
27. Moore CP, Wilsman NJ, Nordheim EV et al. Density and distribution of canine conjunctival goblet cells. Investigative Ophthalmology and Visual Science 1987; 28: 1925-1932.
28. Kinoshita S, Kiorpes TC, Friend J et al. Goblet cell density in ocular surface disease. A better indicator than tear mucin. Archives of Ophthalmology 1983; 101: 1284-1287.
29. Peponis V, Papathanasiou M, Kapranou A et al. Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. British Journal of Ophthalmology 2002; 86: 1369-1373.
30. Murube J, Rivas L. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity. European Journal of Ophthalmology 2003; 13: 115-127.
31. Fullard RJ, Kaswan RM, Bounous DI et al. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS. Journal of the American Optometric Association 1995; 66: 397-404.
32. Moore CP, McHugh JB, Thorne JG et al. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. Investigative Ophthalmology and Visual Science 2001; 42: 653-659.
33. Rosen P, Nawroth PP, King G et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes/Metabolism Research and Reviews 2001; 17: 189-212.
34. Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. Journal of Refractive Surgery 1997; 13: 158-161.
35. Saito J, Enoki M, Hara M et al. Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea 2003; 22: 15-18.
36. Munana KR. Long-term complications of diabetes mellitus, Part I: Retinopathy, nephropathy, neuropathy. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 715-730.
37. Beyer TA, Hutson NJ. Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications. Metabolism 1986; 35: 1-3.
38. Hosotani H, Ohashi Y, Kinoshita S et al. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats. Current Eye Research 1996; 15: 1005-1007.
39. Hosotani H, Ohashi Y, Yamada M et al. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. American Journal of Ophthalmology 1995; 119: 288-294.
40. Fujishima H, Shimazaki J, Yagi Y et al. Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study. Cornea 1996; 15: 368-375.
41. Barrett PM, Scagliotti RH, Merideth RE et al. Absolute corneal sensitivity and corneal trigeminal nerve anatomy in normal dogs. Progress in Veterinary and Comparative Ophthalmology 1991; 1: 245-254.
42. Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea 1996; 15: 229-234.
43. Sullivan DA, Hann LE, Yee L et al. Age- and gender-related influence on the lacrimal gland and tears. Acta Ophthalmologica 1990; 68: 188-194.
44. Roszkowska AM, Colosi P, Ferreri FM et al. Age-related modifications of corneal sensitivity. Ophthalmologica 2004; 218: 350-355.
45. Barcaroli M, Del Beato P, Tanzilli P et al. Diabetes mellitus and dry eye syndrome: tear film glucose level in diabetic patients. Investigative Ophthalmology and Visual Science 1997; 38: S150.
46. Jensen AL. Glycated blood proteins in canine diabetes mellitus. Veterinary Record 1995; 137: 401-405.
47. Loste A, Marca MC. Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs. Veterinary Research 2001; 32: 55-62.